MAIA SCIENTIFIC, a wholly owned subsidiary of Harvard Bioscience, develops, manufactures and markets novel instrumentation and applications for high-throughput / high information content screening. The MIAS-2 microscopy readers, having both brightfield and fluorescence parameters, and the eaZYX imaging software, utilizing the concept of “Scale Space” object oriented analysis algorithms, offer unprecedented sensitivity, speed and flexibility across the drug discovery and development value chain. The MIAS-2 and eaZYX platforms allow genomics, target validation, assay development, drug discovery and ADMET R&D programs to be conducted on the same platform.
MAIA SCIENTIFIC offers contract R&D and OEM Integration
In close collaboration with our partners, we develop innovative platform technologies including mechanization and assay development. Our assay expertise includes cells, tissues, beads, and small animal organisms. Our software and hardware are applied to create a specialized, customer oriented product such as genome research using small model organisms or pre-clinical and clinical dermatology research.